The Relative Strength (RS) Rating for Aflac moved up into a new percentile Wednesday, as it got a lift from 70 to 75.
This proprietary rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks compares to other publicly traded companies.
Decades of market research shows that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating as they launch their largest price moves. See if Aflac can continue to show renewed price strength and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Aflac is working on a flat base with a 115.50 entry. See if it can break out in volume at least 40% higher than normal.
Regarding top and bottom line numbers, the company has posted rising EPS growth over the last three quarters. Revenue gains have been a different story, coming in at -40% in the most recent quarterly report. Aflac is expected to release its next quarterly numbers on or around Feb. 5.
The company holds the No. 4 rank among its peers in the Insurance-Accident & Healthcare industry group. CNO Financial Group is the top-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
